Cupid Limited (CUPID) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cupid Limited (CUPID) has a cash flow conversion efficiency ratio of 0.061x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs233.97 Million ≈ $2.53 Million USD) by net assets (Rs3.81 Billion ≈ $41.22 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See operational self-sufficiency of Cupid Limited to measure how many days the company can operate on defensive assets alone.
Cupid Limited - Cash Flow Conversion Efficiency Trend (2006–2026)
This chart illustrates how Cupid Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Cupid Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cupid Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
MLS Co Ltd
SHE:002745
|
0.010x |
|
Luoyang Longhua Heat Trans Energy
SHE:300263
|
0.024x |
|
Wanda Cinema Line Corp
SHE:002739
|
0.061x |
|
ZTE Corporation
F:FZM
|
0.037x |
|
Levi Strauss & Co Class A
NYSE:LEVI
|
0.124x |
|
Meitu Inc
F:M5U
|
0.013x |
|
Enliven Therapeutics Inc.
NASDAQ:ELVN
|
-0.043x |
|
CREDITACCESS GRAMEEN LIMITED
NSE:CREDITACC
|
0.043x |
Annual Cash Flow Conversion Efficiency for Cupid Limited (2006–2026)
The table below shows the annual cash flow conversion efficiency of Cupid Limited from 2006 to 2026. For the full company profile with market capitalisation and key ratios, see CUPID company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs4.51 Billion ≈ $48.75 Million |
Rs636.97 Million ≈ $6.89 Million |
0.141x | +525.35% |
| 2025-03-31 | Rs3.42 Billion ≈ $37.01 Million |
Rs-113.67 Million ≈ $-1.23 Million |
-0.033x | -227.62% |
| 2024-03-31 | Rs3.01 Billion ≈ $32.58 Million |
Rs78.42 Million ≈ $848.13K |
0.026x | -86.70% |
| 2023-03-31 | Rs1.67 Billion ≈ $18.07 Million |
Rs327.11 Million ≈ $3.54 Million |
0.196x | +171.82% |
| 2022-03-31 | Rs1.42 Billion ≈ $15.38 Million |
Rs102.39 Million ≈ $1.11 Million |
0.072x | -77.51% |
| 2021-03-31 | Rs1.31 Billion ≈ $14.15 Million |
Rs418.88 Million ≈ $4.53 Million |
0.320x | +76.18% |
| 2020-03-31 | Rs1.03 Billion ≈ $11.19 Million |
Rs188.00 Million ≈ $2.03 Million |
0.182x | -24.94% |
| 2019-03-31 | Rs759.35 Million ≈ $8.21 Million |
Rs183.81 Million ≈ $1.99 Million |
0.242x | +363.19% |
| 2018-03-31 | Rs656.50 Million ≈ $7.10 Million |
Rs34.31 Million ≈ $371.04K |
0.052x | -85.90% |
| 2017-03-31 | Rs540.02 Million ≈ $5.84 Million |
Rs200.17 Million ≈ $2.16 Million |
0.371x | +3.90% |
| 2016-03-31 | Rs361.30 Million ≈ $3.91 Million |
Rs128.90 Million ≈ $1.39 Million |
0.357x | +25.95% |
| 2015-03-31 | Rs241.98 Million ≈ $2.62 Million |
Rs68.55 Million ≈ $741.29K |
0.283x | +1904.19% |
| 2014-03-31 | Rs186.08 Million ≈ $2.01 Million |
Rs-2.92 Million ≈ $-31.60K |
-0.016x | -115.79% |
| 2013-03-31 | Rs185.56 Million ≈ $2.01 Million |
Rs18.45 Million ≈ $199.57K |
0.099x | -13.30% |
| 2012-03-31 | Rs166.45 Million ≈ $1.80 Million |
Rs19.09 Million ≈ $206.47K |
0.115x | +195.36% |
| 2011-03-31 | Rs154.06 Million ≈ $1.67 Million |
Rs5.98 Million ≈ $64.70K |
0.039x | +290.14% |
| 2010-03-31 | Rs140.17 Million ≈ $1.52 Million |
Rs-2.86 Million ≈ $-30.96K |
-0.020x | +42.91% |
| 2009-03-31 | Rs150.81 Million ≈ $1.63 Million |
Rs-5.40 Million ≈ $-58.35K |
-0.036x | -119.25% |
| 2008-03-31 | Rs177.01 Million ≈ $1.91 Million |
Rs32.89 Million ≈ $355.72K |
0.186x | +113.79% |
| 2007-03-31 | Rs152.87 Million ≈ $1.65 Million |
Rs13.29 Million ≈ $143.69K |
0.087x | -63.37% |
| 2006-03-31 | Rs105.91 Million ≈ $1.15 Million |
Rs25.13 Million ≈ $271.78K |
0.237x | -- |
About Cupid Limited
Cupid Limited designs, manufactures, markets, and exports male and female condoms in India. The company offers water based lubricant jellies; in vitro diagnostic kits, including rapid diagnostic, viral transport medium, typhoid antibody, syphilis antibody, HIV 1 and 2 kit antibody, dengue IgG/IgM, malaria Pf-Pv and Pf-PAN antigen, hepatitis B (HbsAg) antigen, hepatitis C (HCV) antibody, pregnancy… Read more